Primary resistance to cetuximab therapy in EGFR FISH-positive colorectal cancer patients
- Author
- CAPPUZZO, F1 ; VARELLA-GARCIA, M2 ; HOLMES, A. J5 ; TOSCHI, L5 ; TALLINI, G4 ; DESTRO, A1 ; RONCALLI, M6 ; SANTORO, A1 ; JÄNNE, P. A5 ; FINOCCHIARO, G1 2 ; SKOKAN, M2 ; GAJAPATHY, S2 ; CARNAGHI, C1 ; RIMASSA, L1 ; ROSSI, E3 ; LIGORIO, C1 4 ; DI TOMMASO, L1
[1] Department of Medical Oncology, Istituto Clinico Humanitas IRCCS, Milan University, Rozzano, Italy
[2] Department of Medicine/Medical Oncology, University of Colorado Cancer Center, Aurora, CO, United States
[3] CINECA-Interuniversity Consortium, Bologna, Italy
[4] Pathology Unit, Bologna University, Bellaria Hospital, Bologna, Italy
[5] Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States
[6] Pathology Unit, Istituto Clinico Humanitas IRCCS, Milan University, Rozzano, Italy - Source
British journal of cancer. 2008, Vol 99, Num 1, pp 83-89, 7 p ; ref : 1 p.1/4
- CODEN
- BJCAAI
- ISSN
- 0007-0920
- Scientific domain
- Medical oncology
- Publisher
- Nature Publishing Group, Basingstoke
- Publication country
- United Kingdom
- Document type
- Article
- Language
- English
- Author keyword
- BRAF EGFR IGFIR KRAS MET cetuximab
- Keyword (fr)
- Anticancéreux Cancer colorectal Cancérologie Cétuximab Gène K ras Gène onc cellulaire Homme Hybridation in situ fluorescence Immunothérapie Protooncogène Récepteur facteur croissance épiderme Résistance traitement Traitement Anti-EGFR Gène BRAF Récepteur IGF1R Anticorps monoclonal Cancer Génétique Pathologie de l'appareil digestif Pathologie de l'intestin Pathologie du côlon Pathologie du rectum Tumeur maligne
- Keyword (en)
- Antineoplastic agent Colorectal cancer Cancerology Cetuximab K ras Gene C-Onc gene Human Fluorescence in situ hybridization Immunotherapy Protooncogene Epidermal growth factor receptor Treatment resistance Treatment BRAF Gene type I insulin-like growth factor receptor Monoclonal antibody Cancer Genetics Digestive diseases Intestinal disease Colonic disease Rectal disease Malignant tumor
- Keyword (es)
- Anticanceroso Cancer de colon y recto Cancerología Cetuximab Gen K ras Gen onc celular Hombre Hibridación in situ fluorescencia Inmunoterapia Protooncogen Receptor del factor de crecimiento epidérmico Resistencia tratamiento Tratamiento Gen BRAF Anticuerpo monoclonal Cáncer Genética Aparato digestivo patología Intestino patología Colón patología Recto patología Tumor maligno
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02R Antineoplastic agents / 002B02R03 Immunotherapy
- Discipline
- Pharmacological treatments Tumours
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 20509077
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1038/sj.bjc.6604439 
https://dx.doi.org/10.1038/sj.bjc.6604439
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:22:\"10.1038\/sj.bjc.6604439\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:88:\"Primary resistance to cetuximab therapy in EGFR FISH-positive colorectal cancer patients\";s:9:\"\u0000*\u0000jtitle\";s:25:\"British journal of cancer\";s:9:\"\u0000*\u0000stitle\";s:13:\"Br. J. cancer\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:2:\"99\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:2:\"83\";s:8:\"\u0000*\u0000epage\";s:2:\"89\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0007-0920\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"CAPPUZZO\";s:10:\"\u0000*\u0000aufirst\";s:1:\"F\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:16:{i:0;s:17:\"VARELLA-GARCIA, M\";i:1;s:12:\"HOLMES, A. J\";i:2;s:9:\"TOSCHI, L\";i:3;s:10:\"TALLINI, G\";i:4;s:9:\"DESTRO, A\";i:5;s:11:\"RONCALLI, M\";i:6;s:10:\"SANTORO, A\";i:7;s:12:\"J\u00c4NNE, P. A\";i:8;s:14:\"FINOCCHIARO, G\";i:9;s:9:\"SKOKAN, M\";i:10;s:12:\"GAJAPATHY, S\";i:11;s:11:\"CARNAGHI, C\";i:12;s:10:\"RIMASSA, L\";i:13;s:8:\"ROSSI, E\";i:14;s:10:\"LIGORIO, C\";i:15;s:13:\"DI TOMMASO, L\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"BJCAAI\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:88:\"Primary resistance to cetuximab therapy in EGFR FISH-positive colorectal cancer patients\";s:8:\"\u0000*\u0000place\";s:11:\"Basingstoke\";s:6:\"\u0000*\u0000pub\";s:23:\"Nature Publishing Group\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:22:\"10.1038\/sj.bjc.6604439\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:88:\"Primary resistance to cetuximab therapy in EGFR FISH-positive colorectal cancer patients\";s:9:\"\u0000*\u0000jtitle\";s:25:\"British journal of cancer\";s:9:\"\u0000*\u0000stitle\";s:13:\"Br. J. cancer\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:2:\"99\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:2:\"83\";s:8:\"\u0000*\u0000epage\";s:2:\"89\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0007-0920\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"CAPPUZZO\";s:10:\"\u0000*\u0000aufirst\";s:1:\"F\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:16:{i:0;s:17:\"VARELLA-GARCIA, M\";i:1;s:12:\"HOLMES, A. J\";i:2;s:9:\"TOSCHI, L\";i:3;s:10:\"TALLINI, G\";i:4;s:9:\"DESTRO, A\";i:5;s:11:\"RONCALLI, M\";i:6;s:10:\"SANTORO, A\";i:7;s:12:\"J\u00c4NNE, P. A\";i:8;s:14:\"FINOCCHIARO, G\";i:9;s:9:\"SKOKAN, M\";i:10;s:12:\"GAJAPATHY, S\";i:11;s:11:\"CARNAGHI, C\";i:12;s:10:\"RIMASSA, L\";i:13;s:8:\"ROSSI, E\";i:14;s:10:\"LIGORIO, C\";i:15;s:13:\"DI TOMMASO, L\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"BJCAAI\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:88:\"Primary resistance to cetuximab therapy in EGFR FISH-positive colorectal cancer patients\";s:8:\"\u0000*\u0000place\";s:11:\"Basingstoke\";s:6:\"\u0000*\u0000pub\";s:23:\"Nature Publishing Group\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:22:\"10.1038\/sj.bjc.6604439\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:22:\"10.1038\/sj.bjc.6604439\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:88:\"Primary resistance to cetuximab therapy in EGFR FISH-positive colorectal cancer patients\";s:9:\"\u0000*\u0000jtitle\";s:25:\"British journal of cancer\";s:9:\"\u0000*\u0000stitle\";s:13:\"Br. J. cancer\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:2:\"99\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:2:\"83\";s:8:\"\u0000*\u0000epage\";s:2:\"89\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0007-0920\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"CAPPUZZO\";s:10:\"\u0000*\u0000aufirst\";s:1:\"F\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:16:{i:0;s:17:\"VARELLA-GARCIA, M\";i:1;s:12:\"HOLMES, A. J\";i:2;s:9:\"TOSCHI, L\";i:3;s:10:\"TALLINI, G\";i:4;s:9:\"DESTRO, A\";i:5;s:11:\"RONCALLI, M\";i:6;s:10:\"SANTORO, A\";i:7;s:12:\"J\u00c4NNE, P. A\";i:8;s:14:\"FINOCCHIARO, G\";i:9;s:9:\"SKOKAN, M\";i:10;s:12:\"GAJAPATHY, S\";i:11;s:11:\"CARNAGHI, C\";i:12;s:10:\"RIMASSA, L\";i:13;s:8:\"ROSSI, E\";i:14;s:10:\"LIGORIO, C\";i:15;s:13:\"DI TOMMASO, L\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"BJCAAI\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:88:\"Primary resistance to cetuximab therapy in EGFR FISH-positive colorectal cancer patients\";s:8:\"\u0000*\u0000place\";s:11:\"Basingstoke\";s:6:\"\u0000*\u0000pub\";s:23:\"Nature Publishing Group\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:22:\"10.1038\/sj.bjc.6604439\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:88:\"Primary resistance to cetuximab therapy in EGFR FISH-positive colorectal cancer patients\";s:9:\"\u0000*\u0000jtitle\";s:25:\"British journal of cancer\";s:9:\"\u0000*\u0000stitle\";s:13:\"Br. J. cancer\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:2:\"99\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:2:\"83\";s:8:\"\u0000*\u0000epage\";s:2:\"89\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0007-0920\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"CAPPUZZO\";s:10:\"\u0000*\u0000aufirst\";s:1:\"F\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:16:{i:0;s:17:\"VARELLA-GARCIA, M\";i:1;s:12:\"HOLMES, A. J\";i:2;s:9:\"TOSCHI, L\";i:3;s:10:\"TALLINI, G\";i:4;s:9:\"DESTRO, A\";i:5;s:11:\"RONCALLI, M\";i:6;s:10:\"SANTORO, A\";i:7;s:12:\"J\u00c4NNE, P. A\";i:8;s:14:\"FINOCCHIARO, G\";i:9;s:9:\"SKOKAN, M\";i:10;s:12:\"GAJAPATHY, S\";i:11;s:11:\"CARNAGHI, C\";i:12;s:10:\"RIMASSA, L\";i:13;s:8:\"ROSSI, E\";i:14;s:10:\"LIGORIO, C\";i:15;s:13:\"DI TOMMASO, L\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"BJCAAI\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:88:\"Primary resistance to cetuximab therapy in EGFR FISH-positive colorectal cancer patients\";s:8:\"\u0000*\u0000place\";s:11:\"Basingstoke\";s:6:\"\u0000*\u0000pub\";s:23:\"Nature Publishing Group\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:22:\"10.1038\/sj.bjc.6604439\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:88:\"Primary resistance to cetuximab therapy in EGFR FISH-positive colorectal cancer patients\";s:9:\"\u0000*\u0000jtitle\";s:25:\"British journal of cancer\";s:9:\"\u0000*\u0000stitle\";s:13:\"Br. J. cancer\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:2:\"99\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:2:\"83\";s:8:\"\u0000*\u0000epage\";s:2:\"89\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0007-0920\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"CAPPUZZO\";s:10:\"\u0000*\u0000aufirst\";s:1:\"F\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:16:{i:0;s:17:\"VARELLA-GARCIA, M\";i:1;s:12:\"HOLMES, A. J\";i:2;s:9:\"TOSCHI, L\";i:3;s:10:\"TALLINI, G\";i:4;s:9:\"DESTRO, A\";i:5;s:11:\"RONCALLI, M\";i:6;s:10:\"SANTORO, A\";i:7;s:12:\"J\u00c4NNE, P. A\";i:8;s:14:\"FINOCCHIARO, G\";i:9;s:9:\"SKOKAN, M\";i:10;s:12:\"GAJAPATHY, S\";i:11;s:11:\"CARNAGHI, C\";i:12;s:10:\"RIMASSA, L\";i:13;s:8:\"ROSSI, E\";i:14;s:10:\"LIGORIO, C\";i:15;s:13:\"DI TOMMASO, L\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"BJCAAI\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:88:\"Primary resistance to cetuximab therapy in EGFR FISH-positive colorectal cancer patients\";s:8:\"\u0000*\u0000place\";s:11:\"Basingstoke\";s:6:\"\u0000*\u0000pub\";s:23:\"Nature Publishing Group\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
